The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

Potential signal: <li /> I am a seller of this pair, right here, right now. <li /> I would have a stop loss at 1.0510 and would be aiming for a ...

The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.

The government agency says X no longer suits its communication needs.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) announced Friday that an expert panel of the EU drug regulator, the European ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...

As users continue to leave X (formerly Twitter) en masse, many in favor of the newer Bluesky platform, the European Medicines ...